These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19690235)

  • 41. Dose-related differences in the pharmacodynamic and toxicologic response to a novel hyperglycosylated analog of recombinant human erythropoietin in Sprague-Dawley rats with similarly high hematocrit.
    Andrews DA; Boren BM; Turk JR; Boyce RW; He YD; Hamadeh HK; Mytych DT; Barger TE; Salimi-Moosavi H; Sloey B; Elliott S; McElroy P; Sinclair AM; Shimamoto G; Pyrah IT; Lightfoot-Dunn RM
    Toxicol Pathol; 2014; 42(3):524-39. PubMed ID: 23674391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The erythropoietic effects of interleukin 6 and erythropoietin in vivo.
    Ulich TR; del Castillo J; Yin SM; Egrie JC
    Exp Hematol; 1991 Jan; 19(1):29-34. PubMed ID: 1989892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.
    ; Glaspy J; Vadhan-Raj S; Patel R; Bosserman L; Hu E; Lloyd RE; Boccia RV; Tomita D; Rossi G
    J Clin Oncol; 2006 May; 24(15):2290-7. PubMed ID: 16710026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RETRA: evaluating the transfusion rate with darbepoetin alfa 500 µg every 3 weeks in anaemic cancer patients receiving chemotherapy.
    Eisterer W; Hussl C; Erb H; Haslbauer F; Sormann S; Braun S; Jaeger C
    Curr Med Res Opin; 2011 Feb; 27(2):355-63. PubMed ID: 21166611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anemia management with darbepoetin-alfa in outpatient hemodialysis patients switched from epoetin-alfa: a community hospital experience.
    Agrawal V; Mukherjee S; Kosuri R; Dumler F
    Am J Ther; 2010; 17(5):469-75. PubMed ID: 19770634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of anemia with darbepoetin alfa in heart failure.
    Abraham WT; Anand IS; Klapholz M; Ponikowski P; Scarlata D; Wasserman SM; van Veldhuisen DJ
    Congest Heart Fail; 2010; 16(3):87-95. PubMed ID: 20557327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia.
    Bastit L; Vandebroek A; Altintas S; Gaede B; Pintér T; Suto TS; Mossman TW; Smith KE; Vansteenkiste JF
    J Clin Oncol; 2008 Apr; 26(10):1611-8. PubMed ID: 18375890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of darbepoetin alfa on renal anemia in Japanese hemodialysis patients.
    Kusaba T; Ishida R; Nakayama M; Kato H; Uchiyama H; Sato K; Mori Y; Matsubara H; Kajita Y
    Arzneimittelforschung; 2009; 59(9):435-9. PubMed ID: 19856789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exposure-response modeling of darbepoetin alfa in anemic patients with chronic kidney disease not receiving dialysis.
    Doshi S; Chow A; Pérez Ruixo JJ
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):75S-90S. PubMed ID: 20881221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.
    Hesketh PJ; Arena F; Patel D; Austin M; D'Avirro P; Rossi G; Colowick A; Schwartzberg L; Bertoli LF; Cole JT; Demetri G; Dessypris E; Dobbs T; Eisenberg P; Fleischman R; Hall J; Hoffman PC; Laber DA; Leonard J; Lester EP; McCachren S; McMeekin S; Meza L; Miller DS; Nand S; Oliff I; Paroly W; Pawl L; Perez A; Raftopoulos H; Rigas J; Rowland K; Scullin DC; Tezcan H; Waples J; Ward J; Yee LK
    Cancer; 2004 Feb; 100(4):859-68. PubMed ID: 14770445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilization of darbepoetin alfa in relation to cancer patients' hemoglobin levels.
    Hess G; Hill J; Clough J; Hulnick S; Nordyke RJ
    Curr Med Res Opin; 2008 Mar; 24(3):815-9. PubMed ID: 18257979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart.
    Gao E; Boucher M; Chuprun JK; Zhou RH; Eckhart AD; Koch WJ
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H60-8. PubMed ID: 17384131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of darbepoetin in doxorubicin-induced cardiorenal injury in rats.
    Noiri E; Nagano N; Negishi K; Doi K; Miyata S; Abe M; Tanaka T; Okamoto K; Hanafusa N; Kondo Y; Ishizaka N; Fujita T
    Nephron Exp Nephrol; 2006; 104(1):e6-e14. PubMed ID: 16707910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythropoietin formation in rats with experimental hypersplenism.
    Brabec V; Neuwirt J
    Scand J Haematol; 1975 Apr; 14(2):86-90. PubMed ID: 1145116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipopolysaccharide interference in erythropoiesis in mice.
    Brendt P; Rehfeld I; Kamphausen A; Kreissig C; Peters J
    Anaesthesia; 2012 May; 67(5):493-500. PubMed ID: 22352462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of newborn-like hemoglobin synthesis in adult rats by recombinant human erythropoietin and suppression by aspirin.
    Abdelrahman HG; Srivastava KK; Datta MC
    Acta Haematol; 1996; 96(4):214-20. PubMed ID: 8922487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nucleoside deaminase: an enzymatic marker for stress erythropoiesis in the mouse.
    Rothman IK; Zanjani ED; Gordon AS; Silber R
    J Clin Invest; 1970 Nov; 49(11):2051-67. PubMed ID: 5475986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dose-dependent effect of recombinant erythropoietin on the reticulocyte population of rats.
    Eder H; Rosslenbroich B; Failing K
    Blut; 1989 Aug; 59(2):184-7. PubMed ID: 2475191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute Anemia Induces Erythropoiesis in Rat Organ Surface Primo-Vascular Tissue.
    Shen Y; Lim CJ; Lee SY; Ryu PD
    Adv Exp Med Biol; 2020; 1232():385-392. PubMed ID: 31893435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.